5-methyl-3-(3-nitrophenyl)-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 2g

trans-octahydro-2H-1,4-benzoxazine hydrobromide, 95.0%, 250mg

[4-(Dimethylamino)phenyl]Bis(tertbutyl)phosphine, 95.00%, 10g

1-Isopropyl-1H-pyrrole-2-carbaldehyde, 95.0%, 250mg

6-Bromooxindole, 98.0%, 5g

1-(4-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (Ibrutinib Impurity), 97%, 50mg

3-bromo-5-cyclopropyl-1,2,4-oxadiazole, 95.0%, 250mg

6-Chloro-2-methyl-pyridine-3-sulfonyl chloride, 95.0%, 1g

Kainic Acid, >99%, 1mg

Benzoesäure, min. 99,5 %, Ph.Eur., USP, BP, 500 g, kunststoffverpackung.

6-Benzyloxy-5-methoxy-1H-indole-2-carboxylic acid ethyl ester, 95.0%, 250mg

N,N,N',N'-Tetramethyl-1,6-diaminohexane>98.0%(GC)(T)500mL

Diethyl 1,1-Cyclohexanedicarboxylate>95.0%(GC)1g